Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Ademà

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biopreservation and Biobanking|July 31, 2014
Paraffin treasures: do they last forever?Vera Ademà, Erica Torres, Francesc Solé, et al.
Biopreservation and Biobanking|June 7, 2017
Inspecting Targeted Deep Sequencing of Whole Genome Amplified DNA Versus Fresh DNA for Somatic Mutation Detection: A Genetic Study in Myelodysplastic Syndrome PatientsLaura Palomo, Francisco Fuster-Tormo, Daniel Alvira, et al.
Cancer Cell|September 23, 2014
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDSRebekka K Schneider, Vera Ademà, Dirk Heckl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2013
Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndromeDavid Valcárcel, Vera Ademà, Francesc Solé, et al.
Blood|June 24, 2020
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasmsLaura Palomo, Manja Meggendorfer, Stephan Hutter, et al.
American Journal of Hematology|October 29, 2015
Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphasesLaura Palomo, Blanca Xicoy, Olga Garcia, et al.
Oncotarget|August 4, 2016
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic featuresLaura Palomo, Olga Garcia, Montse Arnan, et al.
Leukemia & Lymphoma|March 11, 2015
Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromesJudit Sánchez-Castro, Víctor Marco-Betés, Xavier Gómez-Arbonés, et al.
Leukemia Research|January 23, 2013
Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?Vera Ademà, Jesús María Hernández, María Abáigar, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biopreservation and Biobanking|July 31, 2014
Paraffin treasures: do they last forever?Vera Ademà, Erica Torres, Francesc Solé, et al.
Biopreservation and Biobanking|June 7, 2017
Inspecting Targeted Deep Sequencing of Whole Genome Amplified DNA Versus Fresh DNA for Somatic Mutation Detection: A Genetic Study in Myelodysplastic Syndrome PatientsLaura Palomo, Francisco Fuster-Tormo, Daniel Alvira, et al.
Cancer Cell|September 23, 2014
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDSRebekka K Schneider, Vera Ademà, Dirk Heckl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2013
Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndromeDavid Valcárcel, Vera Ademà, Francesc Solé, et al.
Blood|June 24, 2020
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasmsLaura Palomo, Manja Meggendorfer, Stephan Hutter, et al.
American Journal of Hematology|October 29, 2015
Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphasesLaura Palomo, Blanca Xicoy, Olga Garcia, et al.
Oncotarget|August 4, 2016
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic featuresLaura Palomo, Olga Garcia, Montse Arnan, et al.
Leukemia & Lymphoma|March 11, 2015
Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromesJudit Sánchez-Castro, Víctor Marco-Betés, Xavier Gómez-Arbonés, et al.
Leukemia Research|January 23, 2013
Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?Vera Ademà, Jesús María Hernández, María Abáigar, et al.
Pageof 1